Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 StudyDIETERICH, Douglas; ROCKSTROH, Jürgen Kurt; PEETERS, Monika et al.Clinical infectious diseases. 2014, Vol 59, Num 11, pp 1579-1587, issn 1058-4838, 9 p.Article

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialJACOBSON, Ira M; DORE, Gregory J; OUWERKERK-MAHADEVAN, Sivi et al.Lancet (British edition). 2014, Vol 384, Num 9941, pp 403-413, issn 0140-6736, 11 p.Article

Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporterCASES-THOMAS, Manuel J; MASTERS, John J; DEFRANCE, Thierry et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 7, pp 2022-2025, issn 0960-894X, 4 p.Article

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised studyLAWITZ, Eric; SULKOWSKI, Mark S; LIM, Joseph K et al.Lancet (British edition). 2014, Vol 384, Num 9956, pp 1756-1765, issn 0140-6736, 10 p.Article

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trialMANNS, Michael; MARCELLIN, Patrick; LENZ, Oliver et al.Lancet (British edition). 2014, Vol 384, Num 9941, pp 414-426, issn 0140-6736, 13 p.Article